Oscar Health is rerated as a bullish pick, driven by ACA enrollment expansion into Alabama, Southern Florida, and other high-growth regions. OSCR projects a 2027 market reach of 24 million members without subsidies and 31 million with subsidies, supporting robust revenue growth. Despite regulatory uncertainty around ACA subsidies expiring after 2025, OSCR's expansion, affordable plans, and innovative offerings position it well for membership growth.
Oscar Health faces ACA subsidy expiration, but aggressive repricing and ICHRA expansion support a contrarian investment thesis. Analysts project FY26 revenue of $12.6bn despite anticipated 10–20% ACA enrollment declines, driven by premium hikes offsetting volume loss and stabilizing MLR. Management's target of 2027 EPS of $2.25 and 5% operating margin implies a forward P/E of 7.6x and EV/EBIT of 4.3x. Based on these targets, OSCR could be materially undervalued.
Here is how Arcosa (ACA) and DIRTT Environmental Solutions Ltd. (DRTTF) have performed compared to their sector so far this year.
| Transportation Infrastructure Industry | Industrials Sector | Antonio Carrillo CEO | XFRA Exchange | US0396531008 ISIN |
| US Country | 6,250 Employees | 15 Oct 2025 Last Dividend | - Last Split | 30 Oct 2018 IPO Date |
Arcosa, Inc., together with its subsidiaries, stands as a prominent provider of infrastructure-related products and solutions primarily catering to the construction, engineered structures, and transportation markets within the United States. It holds a diversified portfolio of products and services across three primary segments: Construction Products, Engineered Structures, and Transportation Products. Since its incorporation in 2018, Arcosa has established its headquarters in Dallas, Texas, marking its strategic position to serve a wide range of markets with its extensive offerings.